Literature DB >> 30474051

Dietary Polysaccharides in the Amelioration of Gut Microbiome Dysbiosis and Metabolic Diseases.

Shokouh Ahmadi1,2,3, Rabina Mainali1,2, Ravinder Nagpal1,2, Mahmoud Sheikh-Zeinoddin3, Sabihe Soleimanian-Zad3,4, Shaohua Wang1,2, Gagan Deep5, Santosh Kumar Mishra6, Hariom Yadav1,2.   

Abstract

The prevalence of metabolic diseases including obesity, diabetes, cardiovascular diseases, hypertension and cancer has evolved into a global epidemic over the last century. The rate of these disorders is continuously rising due to the lack of effective preventative and therapeutic strategies. This warrants for the development of novel strategies that could help in the prevention, treatment and/ or better management of such disorders. Although the complex pathophysiology of these metabolic diseases is one of the major hurdles in the development of preventive and/or therapeutic strategies, there are some factors that are or can speculated to be more effective to target than others. Recently, gut microbiome has emerged as one of the major contributing factors in metabolic diseases, and developing positive modulators of gut microbiota is being considered to be of significant interest. Natural non-digestible polysaccharides from plants and food sources are considered potent modulators of gut microbiome that can feed certain beneficial microbes in the gut. This has led to an increased interest in the isolation of novel bioactive polysaccharides from different plants and food sources and their application as functional components to modulate the gut microbiome composition to improve host's health including metabolism. Therefore, polysaccharides, as prebiotics components, are being speculated to confer positive effects in managing metabolic diseases like obesity and diabetes. In this review article, we summarize some of the most common polysaccharides from plants and food that impact metabolic health and discuss why and how these could be helpful in preventing or ameliorating metabolic diseases such as obesity, type 2 diabetes, hypertension and dyslipidemia.

Entities:  

Keywords:  Diabetes; Dyslipidemia; Gut; Hypertension; Metabolic syndrome; Microbiome; Microbiota; Obesity; Polysaccharides; Prebiotic; Probiotics

Year:  2017        PMID: 30474051      PMCID: PMC6249025          DOI: 10.15226/2374-8354/4/2/00140

Source DB:  PubMed          Journal:  Obes Control Ther        ISSN: 2374-8354


  127 in total

1.  Gut microbiota and bile acids: an old story revisited (again).

Authors:  Noémie Péan; Isabelle Doignon; Thierry Tordjmann
Journal:  Clin Res Hepatol Gastroenterol       Date:  2013-07-31       Impact factor: 2.947

2.  Concepts of insulin resistance.

Authors:  Zachary T Bloomgarden
Journal:  Metab Syndr Relat Disord       Date:  2005       Impact factor: 1.894

Review 3.  Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.

Authors:  Nathalie Esser; Sylvie Legrand-Poels; Jacques Piette; André J Scheen; Nicolas Paquot
Journal:  Diabetes Res Clin Pract       Date:  2014-04-13       Impact factor: 5.602

4.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

5.  Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.

Authors:  Scott V Monte; Joseph A Caruana; Husam Ghanim; Chang Ling Sia; Kelly Korzeniewski; Jerome J Schentag; Paresh Dandona
Journal:  Surgery       Date:  2011-11-16       Impact factor: 3.982

6.  Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue-specific manner.

Authors:  D Panarotto; P Rémillard; L Bouffard; P Maheux
Journal:  Eur J Clin Invest       Date:  2002-02       Impact factor: 4.686

7.  Effects of four Bifidobacteria on obesity in high-fat diet induced rats.

Authors:  Ya-Ni Yin; Qiong-Fen Yu; Nian Fu; Xiao-Wei Liu; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

Review 8.  Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.

Authors:  G M Reaven
Journal:  Panminerva Med       Date:  2005-12       Impact factor: 5.197

Review 9.  Gut Microbiota Modulation and Its Relationship with Obesity Using Prebiotic Fibers and Probiotics: A Review.

Authors:  Dinesh K Dahiya; Monica Puniya; Umesh K Shandilya; Tejpal Dhewa; Nikhil Kumar; Sanjeev Kumar; Anil K Puniya; Pratyoosh Shukla
Journal:  Front Microbiol       Date:  2017-04-04       Impact factor: 5.640

10.  Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice.

Authors:  A M Neyrinck; V F Van Hée; N Piront; F De Backer; O Toussaint; P D Cani; N M Delzenne
Journal:  Nutr Diabetes       Date:  2012-01-23       Impact factor: 5.097

View more
  17 in total

1.  An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota.

Authors:  Shokouh Ahmadi; Shaohua Wang; Ravinder Nagpal; Rabina Mainali; Sabihe Soleimanian-Zad; Dalane Kitzman; Hariom Yadav
Journal:  J Vis Exp       Date:  2019-07-31       Impact factor: 1.355

2.  Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome-gut-brain axis modulation.

Authors:  Shokouh Ahmadi; Ravinder Nagpal; Shaohua Wang; Jason Gagliano; Dalane W Kitzman; Sabihe Soleimanian-Zad; Mahmoud Sheikh-Zeinoddin; Russel Read; Hariom Yadav
Journal:  J Nutr Biochem       Date:  2019-01-30       Impact factor: 6.048

3.  Effects of different drying methods on the physicochemical properties and antioxidant activities of isolated acorn polysaccharides.

Authors:  Shokouh Ahmadi; Mahmoud Sheikh-Zeinoddin; Sabihe Soleimanian-Zad; Farzaneh Alihosseini; Hariom Yadav
Journal:  Lebensm Wiss Technol       Date:  2019-02       Impact factor: 4.952

Review 4.  Protective Effects of Polysaccharides in Neurodegenerative Diseases.

Authors:  Yinying Wang; Rongsha Chen; Zhongshan Yang; Qian Wen; Xia Cao; Ninghui Zhao; Jinyuan Yan
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

Review 5.  Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome.

Authors:  Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  Nutrients       Date:  2019-08-20       Impact factor: 5.717

Review 6.  Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes.

Authors:  Qiyu Yang; Jing Ouyang; Fengjun Sun; Jiadan Yang
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

Review 7.  Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes.

Authors:  Orsu Prabhakar; Mylipilli Bhuvaneswari
Journal:  Tzu Chi Med J       Date:  2020-10-05

Review 8.  The Role of Short-Chain Fatty Acids in Mediating Very Low-Calorie Ketogenic Diet-Infant Gut Microbiota Relationships and Its Therapeutic Potential in Obesity.

Authors:  Naser A Alsharairi
Journal:  Nutrients       Date:  2021-10-21       Impact factor: 5.717

9.  Association between adiposity levels and cognitive impairment in the Chilean older adult population.

Authors:  Y Concha-Cisternas; F Lanuza; H Waddell; Anne Sillars; A M Leiva; C Troncoso; M A Martinez; M Villagrán; L Mardones; M Martorell; G Nazar; N Ulloa; A M Labraña; X Diaz-Martinez; K Sadarangani; C Alvarez; R Ramirez-Campillo; Alex Garrido-Mendez; Cristian Luarte; Frederick Ho; Stuart R Gray; F Petermann-Rocha; C Celis-Morales
Journal:  J Nutr Sci       Date:  2019-10-09

Review 10.  The Extraction, Functionalities and Applications of Plant Polysaccharides in Fermented Foods: A Review.

Authors:  Theoneste Niyigaba; Diru Liu; Jean de Dieu Habimana
Journal:  Foods       Date:  2021-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.